In two mouse models of ETBF colitis, GPR35 knockout resulted in less body weight loss, less severe colitis, and an increased survival rate at 3–7 days post ETBF colonization, despite no decrease in Il17a expression, a key mediator of ETBF colitis9. Here, IL17A is linked to colitis.